B Lynne Parshall
Director at Cytokinetics Inc (CYTK); Director at Ionis Pharmaceuticals Inc (IONS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 1SEC | CYTKCytokinetics Inc | Sell Plan | 5,00010,784 held (−32%) | $71.48 | $357K | -12.0% |
| Jun 1SEC | CYTKCytokinetics Inc | Sell Plan | 5,00015,784 held (−24%) | $74.08 | $370K | -15.1% |
| Apr 17SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 4,46651,878 held (−8%) | $76.19 | $340K | -40.6% |
| Apr 17SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 53451,344 held (−1%) | $76.97 | $41K | -41.2% |
| Mar 2SEC | CYTKCytokinetics Inc | Sell Plan | 5,00017,933 held (−22%) | $61.21 | $306K | +2.8% |
| Feb 13SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 5,00056,344 held (−8%) | $82.72 | $414K | -45.3% |
| Nov 19SEC | CYTKCytokinetics Inc | Sell Plan | 5,00022,933 held (−18%) | $64.73 | $324K | -2.8% |
| Oct 16SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 5,00061,344 held (−8%) | $71.74 | $359K | -36.9% |
- Sell
Director B Lynne Parshall sold $357K of CYTK at $71.48 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
Director B Lynne Parshall sold $370K of CYTK at $74.08 — pre-scheduled 10b5-1 plan sale.
- Sell
Director B Lynne Parshall sold $340K of IONS at $76.19 — pre-scheduled 10b5-1 plan sale.
- Sell
Director B Lynne Parshall sold $41K of IONS at $76.97 — pre-scheduled 10b5-1 plan sale.
- Sell
Director B Lynne Parshall sold $306K of CYTK at $61.21 — pre-scheduled 10b5-1 plan sale.
- Sell
Director B Lynne Parshall sold $414K of IONS at $82.72 — pre-scheduled 10b5-1 plan sale.